Kent and Medway
Joint Medicines Formulary
NHS Kent and Medway
  • Therapeutic Sections
    • Gastro-intestinal system
    • Cardiovascular system
    • Respiratory system
    • Nervous system
    • Infection
    • Endocrine system
    • Genito-urinary system
    • Immune system and malignant disease
    • Blood and Nutrition
    • Musculoskeletal system
    • Eye
    • Ear, nose and oropharynx
    • Skin
    • Vaccines
    • Anaesthesia
    • Preparations used in diagnosis
    • Emergency treatment of poisoning
    • Wound Management
    • Over the Counter Items
  • K&M ICB Guidelines
    • KMICB - Antimicrobial Guidelines
    • KMICB - Gastro-intestinal system
    • KMICB - Cardiovascular system
    • KMICB - Respiratory system
    • KMICB - Nervous system
    • KMICB - Endocrine system
    • KMICB - Genito-urinary system
    • KMICB - Immune system and malignant disease
    • KMICB - Blood and nutrition
    • KMICB - Musculoskeletal system
    • KMICB - Eye
    • KMICB - Ear, nose and oropharynx
    • KMICB - Skin
    • KMICB - Vaccines
    • KMICB - Shared Care Guidance
    • KMICB - Palliative Care
    • KMICB - Miscellaneous
    • KMICB - Communications
    • KMICB - Stoma Products
    • KMICB - Continence products
    • KMICB - Care Home Resources
    • High Cost Drugs Manual
    • SERMOG Recommendations
  • Maidstone and Tunbridge Wells NHS Trust (MTW)
    • MTW - Antimicrobial Guidelines
    • MTW - Electrolyte Guidelines
    • MTW - Thromboembolism Guidelines
    • MTW - Miscellaneous Guidelines
    • MTW - Drug Request Forms & Procedures
  • Dartford and Gravesham NHS Trust (DGT)
  • Medway Foundation Trust NHS Trust (MFT)
  • East Kent Primary Care and East Kent Hospitals University NHS Foundation Trust (EKHUFT)
    • EK - Local recommendations (Cardiovascular)
    • EK - Local recommendations (Eye)
    • EK - Local recommendations (Gastro-intestinal)
    • EK - Local recommendations (Nose)
    • EK - Local recommendations (Nutrition)
    • EK - Local recommendations (Oropharynx)
    • EK - Local recommendations (Respiratory)
    • EK - Local recommendations (Blood)
    • EK - Local recommendations (Nervous system)
    • EK - Local recommendations (Infection)
    • EK - Local recommendations (Endocrine)
    • EK - Local recommendations (Genito-urinary)
    • EK - Local recommendations (Malignant disease)
    • EK - Local recommendations (Musculoskeletal system)
    • EK - Local recommendations (Skin)
    • EK - Local recommendations (Vaccines)
    • EK - Prescribing Recommendations
  • Using the Formulary
  • Therapeutic Sections
  • K&M ICB Guidelines
  • K&M ICB Medicine Applications
  • K&M ICB Primary Care Newsletters
  • K&M ICB Integrated Medicines Optimisation Commitee (IMOC) Minutes
  • Maidstone and Tunbridge Wells NHS Trust (MTW)
  • Dartford and Gravesham NHS Trust (DGT)
  • Medway Foundation Trust NHS Trust (MFT)
  • East Kent Primary Care and East Kent Hospitals University NHS Foundation Trust (EKHUFT)
  • Intravenous Immunoglobulin (IVIG)
  • Drug Index
  • Search

Drug Index

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

O

  • Obinutuzumab

    High Cost Drug Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Ocrelizumab

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Ocriplasmin

    Ophthalmology Initiation High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Octenidine (Octenisan)

    Go to the EMC website for more information and guidance.
  • Octreotide

    Go to the EMC website for more information and guidance.
  • Ofatumumab

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Ofloxacin

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Ofloxacin

    Ophthalmology Initiation Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Oily phenol

  • Olanzapine

    Go to the EMC website for more information and guidance.
  • Olive oil

    Over the Counter
  • Olmesartan medoxomil

    Go to the EMC website for more information and guidance.
  • Olodaterol

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Olopatadine

    Go to the EMC website for more information and guidance.
  • Omalizumab

    High Cost Drug East Kent Hospital University Foundation Trust ONLY Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Ombitasvir + Paritaprevir + Ritonavir

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Omeprazole

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Ondansetron

    Go to the EMC website for more information and guidance.
  • Opicapone

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Oral rehydration salts

    Over the Counter
  • Oritavancin

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Orlistat

    East Kent Hospital University Foundation Trust ONLY Maidstone and Tunbridge Wells NHS Trust ONLY Medway Foundation Trust ONLY Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Orphenadrine

    Go to the EMC website for more information and guidance.
  • Oseltamivir

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Otosporin

    Go to the EMC website for more information and guidance.
  • Oxazepam

    Go to the EMC website for more information and guidance.
  • Oxcarbazepine

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Oxybuprocaine

    Go to the EMC website for more information and guidance.
  • Oxybutynin

    Go to the EMC website for more information and guidance.
  • Oxycodone

    Controlled Drug Go to the EMC website for more information and guidance.
  • Oxytetracycline

    Go to the EMC website for more information and guidance.
  • Oxytetracycline

    Go to the EMC website for more information and guidance.
  • Oxytocin

    Go to the EMC website for more information and guidance.
  • Oxytocin

    Unlicenced Use Go to the EMC website for more information and guidance.
  • Ozanimod

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • On Formulary Preferred
  • On Formulary Second Line
  • On Formulary Third Line
  • Specialist Initiation
  • Secondary Care Only
  • Not Approved for Formulary

Online Formulary by M.O.M. Systems

NICE guidance is available from https://www.nice.org.uk/guidance All rights reserved. Subject to Notice of rights.
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

© Copyright 2026